Nature's Sunshine Products (NASDAQ:NATR - Get Free Report)'s stock had its "hold (c)" rating reiterated by equities research analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Separately, Canaccord Genuity Group boosted their target price on Nature's Sunshine Products from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $20.50.
Check Out Our Latest Stock Report on Nature's Sunshine Products
Nature's Sunshine Products Stock Performance
NATR opened at $15.00 on Wednesday. The business's fifty day moving average is $16.26 and its two-hundred day moving average is $14.65. The company has a market cap of $264.60 million, a price-to-earnings ratio of 20.27 and a beta of 1.12. Nature's Sunshine Products has a one year low of $11.01 and a one year high of $18.06.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $0.35 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.19. The company had revenue of $114.75 million for the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.
Insider Activity at Nature's Sunshine Products
In related news, EVP Bryant J. Yates sold 5,000 shares of the company's stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $16.77, for a total value of $83,850.00. Following the completion of the transaction, the executive vice president directly owned 102,170 shares in the company, valued at approximately $1,713,390.90. This represents a 4.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Nathan G. Brower sold 9,996 shares of the company's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total value of $165,333.84. Following the completion of the transaction, the executive vice president owned 48,277 shares of the company's stock, valued at $798,501.58. The trade was a 17.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 24,668 shares of company stock worth $409,803. 4.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Nature's Sunshine Products
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its stake in Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock worth $28,000 after acquiring an additional 2,132 shares during the last quarter. MTM Investment Management LLC acquired a new stake in Nature's Sunshine Products during the second quarter worth about $30,000. Raymond James Financial Inc. acquired a new stake in Nature's Sunshine Products during the second quarter worth about $37,000. Williams & Novak LLC acquired a new stake in Nature's Sunshine Products during the second quarter worth about $155,000. Finally, Russell Investments Group Ltd. boosted its position in shares of Nature's Sunshine Products by 351.2% in the first quarter. Russell Investments Group Ltd. now owns 12,398 shares of the company's stock worth $156,000 after buying an additional 9,650 shares during the period. 79.40% of the stock is currently owned by institutional investors and hedge funds.
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.